Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Frontiers in immunology [Front Immunol] NLMUID: 101560960"" wg kryterium: JN


Tytuł:
Intratumoral CXCR4 neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma.
Autorzy:
Lu Z; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang X; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Feng J; Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Chai W; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang W; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang Q; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yang S; Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yang W; Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Su Y; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Mou W; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Peng Y; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang H; Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Gui J; Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1363454. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts.
Autorzy:
Alotaibi FM; College of Science and Health Professions, King Saud Bin Abdulaziz University for Health Sciences, Alahsa, Saudi Arabia.; King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Min WP; Department of Oncology, The University of Western Ontario, London, ON, Canada.
Koropatnick J; Department of Oncology, The University of Western Ontario, London, ON, Canada.; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada.; Cancer Research Laboratory Program, London Regional Cancer Program, Lawson Health Research Institute, London, ON, Canada.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1256766. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Immunoproteomics enable broad identification of new Aspergillus fumigatus antigens in severe equine asthma.
Autorzy:
Jentsch MC; Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Lübke S; Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Schrödl W; Institute of Bacteriology and Mycology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Volke D; Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Centre for Biotechnology and Biomedicine, Leipzig University, Leipzig, Germany.
Krizsan A; Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Centre for Biotechnology and Biomedicine, Leipzig University, Leipzig, Germany.
Hoffmann R; Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Centre for Biotechnology and Biomedicine, Leipzig University, Leipzig, Germany.
Kaiser-Thom S; Swiss Institute of Equine Medicine, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Gerber V; Swiss Institute of Equine Medicine, Department of Clinical Veterinary Medicine, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Marti E; Division of Neurological Sciences, Department of Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Wagner B; Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Schnabel CL; Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1347164. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy.
Autorzy:
Bar J; Institute of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Leibowitz R; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.; Shamir Medical Center, Oncology Institute, Zerifin, Israel.
Reinmuth N; German Center for Lung Research (DZL), Munich-Gauting, Germany.; Biobank of lung disease, Asklepios Klinik Gauting GmbH, Gauting, Germany.
Ammendola A; Biobank of lung disease, Asklepios Klinik Gauting GmbH, Gauting, Germany.
Jacob E; OncoHost LTD, Binyamina, Israel.
Moskovitz M; Thoracic oncology service, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Levy-Barda A; Biobank, Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.
Lotem M; Center for Melanoma and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, Sharett Institute of Oncology, Jerusalem, Israel.
Katsenelson R; Department of Oncology, Kaplan Medical Center, Rehovot, Israel.
Agbarya A; Institute of Oncology, Bnai Zion Medical Center, Haifa, Israel.
Abu-Amna M; Oncology & Hematology Division, Cancer Center, Emek Medical Center, Afula, Israel.
Gottfried M; Department of Oncology, Meir Medical Center, Kfar-Saba, Israel.
Harkovsky T; Barzilai Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Ashkelon, Israel.
Wolf I; Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Tepper E; Department of Oncology, Assuta Hospital, Tel Aviv, Israel.
Loewenthal G; OncoHost LTD, Binyamina, Israel.
Yellin B; OncoHost LTD, Binyamina, Israel.
Brody Y; OncoHost LTD, Binyamina, Israel.
Dahan N; OncoHost LTD, Binyamina, Israel.
Yanko M; OncoHost LTD, Binyamina, Israel.
Lahav C; OncoHost LTD, Binyamina, Israel.
Harel M; OncoHost LTD, Binyamina, Israel.
Raveh Shoval S; OncoHost LTD, Binyamina, Israel.
Elon Y; OncoHost LTD, Binyamina, Israel.
Sela I; OncoHost LTD, Binyamina, Israel.
Dicker AP; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States.
Shaked Y; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1364473. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Corrigendum: OPN promotes pro-inflammatory cytokine expression via ERK/JNK pathway and M1 macrophage polarization in Rosacea.
Autorzy:
Tang S; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
Hu H; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
Li M; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
Zhang K; Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
Wu Q; Greater Bay Biomedical Innocenter, Shenzhen Bay Laboratory, Shenzhen, China.
Liu X; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
Wu L; Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
Yu B; Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
Chen X; Shenzhen Key Laboratory for Translational Medicine of Dermatology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1382092. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Published Erratum
Tytuł:
FcRY is a key molecule controlling maternal blood IgY transfer to yolks during egg development in avian species.
Autorzy:
Okamoto M; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Sasaki R; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Ikeda K; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Doi K; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Tatsumi F; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Oshima K; Laboratory of Molecular Bioregulation, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Kojima T; Laboratory of Molecular Biotechnology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Mizushima S; Department of Biological Sciences, Faculty of Science, Hokkaido University, Sapporo, Japan.
Ikegami K; Laboratory of Animal Integrative Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Yoshimura T; Laboratory of Animal Integrative Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.; Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Nagoya, Japan.
Furukawa K; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Kobayashi M; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Horio F; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Murai A; Laboratory of Animal Nutrition, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1305587. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner.
Autorzy:
Stock AJ; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
Gonzalez Paredes P; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
de Almeida LP; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
Kosanke SD; Heartland Veterinary Pathology Services, PLLC, Edmond, OK, United States.
Chetlur S; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
Budde H; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
Wakenight P; Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States.
Zwingman TA; Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States.
Rosen ABI; Seattle Children's Research Institute, Center for Immunity and Immunotherapies, Seattle, WA, United States.
Allenspach EJ; Seattle Children's Research Institute, Center for Immunity and Immunotherapies, Seattle, WA, United States.; Department of Pediatrics, School of Medicine, University of Washington, Seattle, WA, United States.
Millen KJ; Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States.; Department of Pediatrics, School of Medicine, University of Washington, Seattle, WA, United States.
Buckner JH; Benaroya Research Institute at Virginia Mason, Center for Translational Immunology, Seattle, WA, United States.
Rawlings DJ; Seattle Children's Research Institute, Center for Immunity and Immunotherapies, Seattle, WA, United States.; Department of Pediatrics, School of Medicine, University of Washington, Seattle, WA, United States.; Department of Immunology, School of Medicine, University of Washington, Seattle, WA, United States.
Gorman JA; Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, OK, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1349601. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer.
Autorzy:
Dou T; Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Li J; Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zhang Y; Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Pei W; Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Zhang B; Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Wang B; Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Wang Y; Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.; Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, Taiyuan, Shanxi, China.
Jia H; Department of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.; Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, Taiyuan, Shanxi, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1368687. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Autorzy:
Keijzer S; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Oskam N; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Ooijevaar-de Heer P; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Steenhuis M; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Keijser JBD; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Wieske L; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
van Dam KPJ; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Stalman EW; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Kummer LYL; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Boekel L; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.
Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Ten Brinke A; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
van Ham SM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands.
Eftimov F; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Tas SW; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Wolbink GJ; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, Netherlands.
Rispens T; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1314507. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report.
Autorzy:
Deng W; Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Pulmonary Medicine, Medical Research Center for Pulmonary and Critical Care Medicine, Chongqing, China.
Chen J; Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Pulmonary Medicine, Medical Research Center for Pulmonary and Critical Care Medicine, Chongqing, China.
Deng XY; Department of Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1333850. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Tytuł:
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
Autorzy:
Kenney RT; Sonnet BioTherapeutics, Inc, Princeton, NJ, United States.
Cini JK; Sonnet BioTherapeutics, Inc, Princeton, NJ, United States.
Dexter S; Sonnet BioTherapeutics, Inc, Princeton, NJ, United States.
DaFonseca M; Sonnet BioTherapeutics, Inc, Princeton, NJ, United States.
Bingham J; Momentum Metrix, LLC, Dublin, CA, United States.
Kuan I; Momentum Metrix, LLC, Dublin, CA, United States.
Chawla SP; Sarcoma Oncology Center, Santa Monica, CA, United States.
Polasek TM; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.; InClin, Inc, San Mateo, CA, United States.
Lickliter J; Nucleus Network Pty Ltd, Melbourne, VIC, Australia.
Ryan PJ; Nucleus Network Pty Ltd, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1362775. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
SKAP2 acts downstream of CD11b/CD18 and regulates neutrophil effector function.
Autorzy:
Bouti P; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Klein BJAM; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Verkuijlen PJH; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Schornagel K; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
van Alphen FPJ; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Taris KH; Department of Physics and Astronomy, Vrije Universiteit, Amsterdam, Netherlands.; LaserLaB Amsterdam, Vrije Universiteit, Amsterdam, Netherlands.
van den Biggelaar M; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Hoogendijk AJ; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
van Bruggen R; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Kuijpers TW; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.; Department of Pediatric Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Matlung HL; Department of Molecular Hematology Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, Netherlands.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1344761. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Directing the migration of serum-free, ex vivo -expanded Vγ9Vδ2 T cells.
Autorzy:
Parwani KK; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Branella GM; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Burnham RE; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Burnham AJ; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Bustamante AYS; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Foppiani EM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Knight KA; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Petrich BG; Expression Therapeutics LLC, Tucker, GA, United States.
Horwitz EM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Doering CB; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Spencer HT; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1331322. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Checkpoint CD24 function on tumor and immunotherapy.
Autorzy:
Huang S; Department of Radiology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.; Graduate School, Chinese PLA Medical School, Beijing, China.; Department of Nuclear Medicine, Characteristic Medical Center of the Chinese People's Armed Police Force, Tianjin, China.
Zhang X; Department of Radiology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Wei Y; Department of Radiology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Xiao Y; Department of Radiology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1367959. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.
Autorzy:
Ballestín A; Tumor Microenvironment Laboratory, UMR3347 CNRS/U1021 INSERM, Institut Curie, Orsay, France.
Armocida D; Human Neurosciences Department, Neurosurgery Division, Sapienza University, Rome, Italy.
Ribecco V; Tumor Microenvironment Laboratory, UMR3347 CNRS/U1021 INSERM, Institut Curie, Orsay, France.
Seano G; Tumor Microenvironment Laboratory, UMR3347 CNRS/U1021 INSERM, Institut Curie, Orsay, France.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1347877. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report.
Autorzy:
Zhong G; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Zhang X; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China.
Guo Z; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Gao Y; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Zhao B; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Liu X; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Chen L; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Qiao J; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Yu C; R&D Department, Shenzhen Haoshi Biotechnology Co., Ltd, Shenzhen, China.; Biomedical Laboratory, Shenzhen University-Haoshi Cell Therapy Institute, Shenzhen, China.
Wang L; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.
Li Y; R&D Department, Shenzhen Haoshi Biotechnology Co., Ltd, Shenzhen, China.; Biomedical Laboratory, Shenzhen University-Haoshi Cell Therapy Institute, Shenzhen, China.
Yu L; Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.; Biomedical Laboratory, Shenzhen University-Haoshi Cell Therapy Institute, Shenzhen, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1325860. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Tytuł:
New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era.
Autorzy:
Hu X; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Chen S; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Ye S; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Chen W; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Zhou Y; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1342837. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Approaches of dengue control: vaccine strategies and future aspects.
Autorzy:
Akter R; Department of Pharmacy, Independent University Bangladesh, Dhaka, Bangladesh.; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
Tasneem F; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
Das S; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
Soma MA; Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
Georgakopoulos-Soares I; Institute for Personalized Medicine, Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Juthi RT; Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Sazed SA; Institute for Personalized Medicine, Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1362780. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target.
Autorzy:
Zhang X; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Liu J; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Deng X; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Bo L; Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1281263. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Control of immune cell signaling by the immuno-metabolite itaconate.
Autorzy:
Lang R; Institute of Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Siddique MNAA; Institute of Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 28; Vol. 15, pp. 1352165. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies